Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2025	Jan. 31, 2025
Current assets
Cash and cash equivalents	$ 283,998	$ 186,331
Short-term investments	478,059	518,813
Accounts receivable, net of allowances of $319 and $499	165,596	177,627
Deferred commissions	95,352	91,919
Prepaid expenses and other current assets	93,890	102,951
Total current assets	1,116,895	1,077,641
Noncurrent assets
Property and equipment, net	54,935	53,194
Deferred commissions, noncurrent	125,696	132,465
Goodwill	101,618	100,343
Other assets, noncurrent	75,462	59,331
Total assets	1,474,606	1,422,974
Current liabilities
Accounts payable	9,905	10,439
Accrued expenses and other current liabilities	112,512	162,602
Deferred revenue	838,872	777,135
Total current liabilities	961,289	950,176
Deferred revenue, noncurrent	670,307	642,370
Other liabilities, noncurrent	76,719	61,821
Debt, noncurrent	322,821	322,341
Total liabilities	2,031,136	1,976,708
Commitments and contingencies (Note 9)
Stockholders’ deficit
Preferred stock, $0.000025 par value – $20,000,000 shares authorized as of April 30, 2025 and January 31, 2025; zero shares issued and outstanding as of April 30, 2025 and January 31, 2025	0	0
Additional paid-in capital	2,382,345	2,291,829
Accumulated other comprehensive income (loss)	557	(8,235)
Accumulated deficit	(2,939,437)	(2,837,333)
Total stockholders’ deficit	(556,530)	(553,734)
Total liabilities and stockholders’ deficit	$ 1,474,606	$ 1,422,974
Preferred stock, outstanding (in shares)	0	0
Preferred stock, authorized (in shares)	20,000,000	20,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Class A common stock
Stockholders’ deficit
Common stock	$ 3	$ 3
Common stock, authorized (in shares)	1,070,000,000	1,070,000,000
Class B common stock
Stockholders’ deficit
Common stock	$ 2	$ 2
Common stock, authorized (in shares)	210,000,000	210,000,000